Article
Reformation provides IOP control more safely
Austin, TX-Brimonidine-Purite 0.15% (Alphagan P, Allergan), a new formulation of brimonidine tartrate ophthalmic solution in which benzalkonium chloride has been replaced with Purite, offers IOP-lowering efficacy comparable to brimonidine 0.2% (Alphagan) with the benefit of a superior safety profile, said Thomas R. Walters, MD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
